TLC-Densitometric Determination of Five Coxibs in Pharmaceutical Preparations

被引:9
作者
Gumulka, Pawel [1 ]
Dabrowska, Monika [1 ]
Starek, Malgorzata [1 ]
机构
[1] Jagiellonian Univ, Fac Pharm, Dept Inorgan & Analyt Chem, Med Coll, 9 Medyczna St, PL-30688 Krakow, Poland
关键词
coxibs; TLC-densitometry; validation of the method; human and veterinary drugs; COX-2; INHIBITORS; FIROCOXIB; ETORICOXIB; PLASMA; SAFETY; CYCLOOXYGENASE-2; PHARMACOKINETICS; THIOCOLCHICOSIDE; OSTEOARTHRITIS; ROBENACOXIB;
D O I
10.3390/pr8050620
中图分类号
TQ [化学工业];
学科分类号
0817 ;
摘要
A class of drugs called coxibs (COX-2 inhibitors) were created to help relieve pain and inflammation of osteoarthritis and rheumatoid arthritis with the lowest amount of side effects possible. The presented paper describes a new developed, optimized and validated thin layer chromatographic (TLC)-densitometric procedure for the simultaneous assay of five coxibs: celecoxib, etoricoxib, firecoxib, rofecoxib and cimicoxib. Chromatographic separation was conducted on HPTLC F(254)silica gel chromatographic plates as a stationary phase using chloroform-acetone-toluene (12:5:2,v/v/v) as a mobile phase. Densitometric detection was carried out at two wavelengths of 254 and 290 nm. The method was tested according to ICH guidelines for linearity, recovery and specificity. The presented method was linear in a wide range of concentrations for all analyzed compounds, with correlation coefficients greater than 0.99. The method is specific, precise (%RSD < 1) and accurate (more than 95%, %RSD < 2). Low-cost, simple and rapid, it can be used in laboratories for drug monitoring and quality control.
引用
收藏
页数:15
相关论文
共 42 条
[1]   A comparative study: the prospective influence of nanovectors in leveraging the chemopreventive potential of COX-2 inhibitors against skin cancer [J].
Aasy, Noha Khalifa Abo ;
Ragab, Doaa ;
Sallam, Marwa Ahmed ;
Abdelmonsif, Doaa A. ;
Aly, Rania G. ;
Elkhodairy, Kadria A. .
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2019, 14 :7561-7581
[2]  
[Anonymous], 2000, FDA GUID AN PROC MET
[3]  
[Anonymous], 2005, VAL AN PROC TEXT MET
[4]   Development of validated stability-indicating assay methods - critical review [J].
Bakshi, M ;
Singh, S .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2002, 28 (06) :1011-1040
[5]  
Bergh MS, 2005, J VET INTERN MED, V19, P633, DOI 10.1892/0891-6640(2005)19[633:TCNPCA]2.0.CO
[6]  
2
[7]  
Bjorkman D J, 2001, Rev Gastroenterol Disord, V1, P121
[8]   Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. [J].
Bombardier, C ;
Laine, L ;
Reicin, A ;
Shapiro, D ;
Burgos-Vargas, R ;
Davis, B ;
Day, R ;
Ferraz, MB ;
Hawkey, CJ ;
Hochberg, MC ;
Kvien, TK ;
Schnitzer, TJ ;
Weaver, A .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (21) :1520-1528
[9]   Nonsteroidal anti-inflammatory drugs and cardiovascular risk - a matter of indication [J].
Braun, Juergen ;
Baraliakos, Xenofon ;
Westhoff, Timm .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2020, 50 (02) :285-288
[10]   Disposition of firocoxib in equine plasma after an oral loading dose and a multiple dose regimen [J].
Cox, S. ;
Villarino, N. ;
Sommardahl, C. ;
Kvaternick, V. ;
Zarabadipour, C. ;
Siger, L. ;
Yarbrough, J. ;
Amicucci, A. ;
Reed, K. ;
Breeding, D. ;
Doherty, T. .
VETERINARY JOURNAL, 2013, 198 (02) :382-385